We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Showcases New All-In-One Solution for Molecular Diagnostics at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 05 Feb 2020
Randox Biosciences, a part of Randox Laboratories, (Crumlin, UK), showcased its new Vivalytic molecular diagnostic platform at MEDLAB Middle East, the largest medical laboratory exhibition and congress in the Middle East & North Africa (MENA) region.

Vivalytic is the newest offering from Randox Biosciences for the molecular diagnostic industry to test for respiratory, genitourinary and hospital acquired infections. More...
The Vivalytic platform, which is capable of both Hi-Plex and Lo-Plex testing, combines nucleic acid extraction, PCR amplification followed by a suite of detection methods in a fully automated platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required, making Vivalytic a unique space-saving, hygienic solution for molecular diagnostic testing.

Randox Biosciences also showcased its Evidence series of immunoassay analyzers that have been developed using its patented Biochip Array Technology, which includes multiplex protein immunoassays and multiplex nucleic acid arrays. Biochip Array Technology is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. Biochip provides a unique platform for assessment in a rapid, accurate and easy to use format. Additionally, Randox Quality Control highlighted its newly-launched Infectious Disease Serology Internal Quality Controls, which include Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more. All the samples are provided in a user-friendly, liquid ready-to-use format, thus significantly reducing preparation time and the risk of pipetting errors.

At this year’s MEDLAB Middle East, Randox Laboratories presented its RX series of clinical chemistry analyzers which feature robust hardware combined with intuitive software for ensuring precise and accurate results. Its extensive test menu delivers consolidation and can help to bring testing in house, reducing both costs and time. Additionally, Randox Laboratories showcased its wide range of reagents for advancing biochemistry testing for laboratories, including niche and superior performance assays which cover routine and novel markers. Applications are available detailing instrument-specific settings for the convenient use of Randox reagents on a wide range of clinical chemistry analyzers. Randox Laboratories also highlighted its range of complete QC solutions comprising true third-party controls for a wide range of testing, including molecular infectious diseases, inter-laboratory data management software and the world’s largest international EQA scheme – RIQAS.

Related Links:
Randox Laboratories


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Amoebiasis Test
ELI.H.A Amoeba
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.